EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lacticaseibacillus casei Combats Biofilm Formation and Exhibits Antibacterial Activity Against Clinical Isolates of Staphylococcus aureus, Salmonella enterica, and Escherichia coli

Despoina Eugenia Kiousi iD, Sotiris Kyriakou iD, Christos Efstathiou, Stylianos Didaskalou iD, Maria Koffa iD, Aglaia Pappa iD, Maria Panopoulou, Mihalis I Panayiotidis iD, Alex Galanis iD

Microorganisms · 24.11.2025 · 13 (12) · 2667

DOI: 10.3390/microorganisms13122667 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microorganisms, online erschienen am 24.11.2025. Verfasst von Despoina Eugenia Kiousi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology and Genetics, Faculty of Health Sciences, Democritus University of Thrace, 68100 Alexandroupolis, Greece. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: EPAnEK, Telethon Cyprus.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Biofilm-forming pathogens are a major cause of persistent infections, showing limited response to antibiotic treatment. The search for alternative strategies has therefore driven extensive research into the antimicrobial potential of beneficial microorganisms. In the present study, the antibacterial and antibiofilm activity of the commercial probiotic strain Lacticaseibacillus casei ATCC 393 (Lc393) was examined against clinical isolates of Staphylococcus aureus, Salmonella enterica subsp. enterica serovar Enteritidis and Escherichia coli. Lc393 reduced pathogen viability and attachment to the colon adenocarcinoma cell line HT-29, with maximal effects recorded against S. aureus. Confocal microscopy visualization of the lactobacilli-pathogens-host interface revealed that Lc393 binds loosely to both host cells and pathogens. The Lc393 cell-free culture supernatant (CFCS) significantly reduced planktonic growth, biofilm mass, and viability of cells in biofilm (>2 logCFU reduction, p < 0.05) and downregulated genes involved in the early stages of biofilm formation in S. aureus (i.e., icaA, fnbpA, eno). In silico analysis of the Lc393 genome identified two bacteriocin clusters, along with genes related to ethanol and organic acid production. Based on in silico predictions and a bacteriocin zymogram, the strain cannot produce functional antimicrobial peptides. Untargeted metabolomics based on UPLC/MS further revealed the presence of putative antimicrobial metabolites. Collectively, our findings highlight the antimicrobial potential of Lc. casei ATCC 393 and support its further investigation for combating clinically relevant human pathogens.

Schlagwörter

Stichwörter der Autor:innen

Lacticaseibacillus caseiantibiofilmantimicrobialcell-free culture supernatantspathogensprobioticsuntargeted metabolomics

Autor:innen und Institutionen

  • Department of Molecular Biology and Genetics, Faculty of Health Sciences, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
  • Department of Cancer Genetics, Therapeutics and Ultrastructural Pathology, The Cyprus Institute of Neurology and Genetics, 2371 Nicosia, Cyprus.
  • Department of Medicine, Faculty of Health Sciences, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
  • Department of Comparative Biomedical Sciences, School of Veterinary Medicine, Mississippi State University, Starkville, MS 39762, USA.

ORCID-Profile: Despoina Eugenia Kiousi, Sotiris Kyriakou, Stylianos Didaskalou, Maria Koffa, Aglaia Pappa, Mihalis I Panayiotidis, Alex Galanis

Förderung

  • EPAnEK
  • Telethon Cyprus

Zitieren

APA

Kiousi, D. E., Kyriakou, S., Efstathiou, C., Didaskalou, S., Koffa, M., Pappa, A., Panopoulou, M., Panayiotidis, M. I., & Galanis, A. (2025). Lacticaseibacillus casei Combats Biofilm Formation and Exhibits Antibacterial Activity Against Clinical Isolates of Staphylococcus aureus, Salmonella enterica, and Escherichia coli. Microorganisms, 13(12), 2667. https://doi.org/10.3390/microorganisms13122667

Vancouver

Kiousi DE, Kyriakou S, Efstathiou C, Didaskalou S, Koffa M, Pappa A, et al. Lacticaseibacillus casei Combats Biofilm Formation and Exhibits Antibacterial Activity Against Clinical Isolates of Staphylococcus aureus, Salmonella enterica, and Escherichia coli. Microorganisms. 2025;13(12):2667. doi:10.3390/microorganisms13122667

BibTeX
@article{Kiousi2025,
  author = {Kiousi, Despoina Eugenia and Kyriakou, Sotiris and Efstathiou, Christos and Didaskalou, Stylianos and Koffa, Maria and Pappa, Aglaia and Panopoulou, Maria and Panayiotidis, Mihalis I and Galanis, Alex},
  title = {Lacticaseibacillus casei Combats Biofilm Formation and Exhibits Antibacterial Activity Against Clinical Isolates of Staphylococcus aureus, Salmonella enterica, and Escherichia coli},
  journal = {Microorganisms},
  year = {2025},
  volume = {13},
  number = {12},
  pages = {2667},
  doi = {10.3390/microorganisms13122667}
}
Kostenlos starten →